Lung cancer (non-small-cell) - pemetrexed

Pemetrexed for the treatment of non-small-cell lung cancer

Summary

• Pemetrexed is not recommended for the treatment of locally advanced or metastatic non-small-cell lung cancer.
• People currently receiving pemetrexed should have the option to continue therapy until they and their clinicians consider it appropriate to stop.

Guidance documents

• Guidance PDF format
• Quick reference guide PDF format
• Understanding NICE guidance PDF format
• TA124 Lung cancer (non-small cell) - pemetrexed: guidance (MS Word format)
• TA124 Lung cancer (non-small cell) - pemetrexed: understanding NICE guidance (MS Word format)

Implementing this guidance

• Cost report
• Audit criteria

• How this guidance was produced
• Background information

We will consult on our review plans for this guidance in January 2010